Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of British Columbia

$105,000.00

Engineering anucleate platelets for the delivery of RNA

FY 2013-14

Summary
Local delivery of therapeutic agents remains one of the major challenges in medicine, particularly in cardiovascular disease and the treatment of atherosclerosis. Atherosclerosis can cause excessive blood clotting, leading to heart attack and stroke. These are two of the three major causes of death in Canada; nearly 14,000 Canadians die each year from strokes and over 16,000 Canadians die each year from heart attacks. In atherosclerosis only small areas of the blood vessels are diseased, and it is from these plaques that blood clotting can initiate. Local delivery of agents is required to prevent clotting and prevent harmful off-target effects. The goal of my research is to utilize platelets, small cells found within the bloodstream, to help overcome this challenge. Platelets naturally release biomolecules and genetic material at sites of inflammation and disease, making them ideal delivery vehicles for gene-based therapeutics. My research will be focused on manipulating platelets to release and deliver gene-based therapeutics to sites of injury within the bloodstream, utilizing naturally occurring processes. My preliminary work on this project has already developed a technology for delivering non-native genetic materials to platelets and has demonstrated that these materials can be controllably released. My aim is to optimize this technology to allow for the delivery of therapeutically-relevant material, and show delivery and utilization of the gene in target cells in the laboratory. One potential use of this technology is to modify platelets such that they deliver materials that suppress harmful inflammatory processes at atherosclerotic plaques, which would promote healing and prevent unwanted blood clotting in these regions. This platelet delivery system has the potential to reduce the number of heart attacks and strokes each year and would be a completely new approach for treating atherosclerosis, providing a major benefit to the health of Canadians.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
307768
Name
Novakowski Stefanie K
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Engineering anucleate platelets for the delivery of RNA
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Atherosclerosis; Cardiovascular Disease; Delivery Systems; Lipid Nanoparticles; Platelets; Rnai
Abstract
Local delivery of therapeutic agents remains one of the major challenges in medicine, particularly in cardiovascular disease and the treatment of atherosclerosis. Atherosclerosis can cause excessive blood clotting, leading to heart attack and stroke. These are two of the three major causes of death in Canada; nearly 14,000 Canadians die each year from strokes and over 16,000 Canadians die each year from heart attacks. In atherosclerosis only small areas of the blood vessels are diseased, and it is from these plaques that blood clotting can initiate. Local delivery of agents is required to prevent clotting and prevent harmful off-target effects. The goal of my research is to utilize platelets, small cells found within the bloodstream, to help overcome this challenge. Platelets naturally release biomolecules and genetic material at sites of inflammation and disease, making them ideal delivery vehicles for gene-based therapeutics. My research will be focused on manipulating platelets to release and deliver gene-based therapeutics to sites of injury within the bloodstream, utilizing naturally occurring processes. My preliminary work on this project has already developed a technology for delivering non-native genetic materials to platelets and has demonstrated that these materials can be controllably released. My aim is to optimize this technology to allow for the delivery of therapeutically-relevant material, and show delivery and utilization of the gene in target cells in the laboratory. One potential use of this technology is to modify platelets such that they deliver materials that suppress harmful inflammatory processes at atherosclerotic plaques, which would promote healing and prevent unwanted blood clotting in these regions. This platelet delivery system has the potential to reduce the number of heart attacks and strokes each year and would be a completely new approach for treating atherosclerosis, providing a major benefit to the health of Canadians.
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Novakowski, Stefanie K
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
University of British Columbia - $105,000 Grant (2013… | Canada Spends